US FDA reengineers Center for Devices and Radiological Health
This article was originally published in Clinica
Corporate America has reengineered itself. Now, learning from that exercise, the US FDA's Center for Devices and Radiological Health is to undertake the same task. At HIMA's annual meeting last week, the CDRH's director, Dr Bruce Burlington, outlined what this would mean to an audience distinctly less hostile than at the same event a year ago. Then the interaction between regulator and regulated descended into verbal fisticuffs; this year's atmosphere was cautiously amicable.